Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Royal Philips
BioIntelliSense is initiating a 2,500-participant virtual study to validate whether its BioSticker can be used for early detection of COVID-19.
After a year like no other for the global medtech industry, 2021 will present a different set of market challenges for device and diagnostic companies.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.